Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Biofrontera (NASDAQ:BFRI) through any online brokerage.
Other companies in Biofrontera’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Biofrontera has a consensus price target of $2.88.
The stock price for Biofrontera (NASDAQ: BFRI) is $1.09 last updated September 30, 2026 at 7:58 PM EDT.
There are no upcoming dividends for Biofrontera.
Biofrontera does not have any upcoming earnings scheduled.
There is no upcoming split for Biofrontera.
Biofrontera is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.